We describe here serological and structural properties of a virus, Mason-Pfizer Monkey Virus (M-PMV), isolated from a simian mammary tumor. This virus is morphologically similar to the known oncogenic RNA viruses (oncornaviruses). It has a 60-70S RNA, and its replication is inhibited by actinomycin. Antisera prepared against the virus isolated by density-gradient centrifugation identify at least two viral structural antigens. 
A tissue culture line of mixed monkey embryo-monkey mammary tumor cells producing M-PMV was kindly provided by Chas. Pfizer and Co., Inc. Virus was concentrated from tissue-culture fluid by ammonium sulfate precipitation (50% saturation) and then layered upon a sucrose density gradient (15-60% sucrose in 0.1 M Tris HCl-0.1 M NaCl buffer, pH 8.0). After centrifugation for 3 hr at 119,000 X g SW 27 rotor), a visible virus band was observed at density 1.16 g/ml. This band was diluted with Tris-NaCl buffer and pelleted by centrifugation for 1 hr at 119,000 X g. 
Antisera
The viral antigen used to prepare antisera came from 1500 ml of culture fluid. 1 mg of Tween 80 plus 0.5 ml of ethyl ether was added to the virus pellet suspended in 0.5 ml TrisNaCl buffer, and the mixture was shaken for 30 min in the cold. The aqueous and ether phases were separated by centrifugation at 1000 X g for 20 min; the aqueous phase, dialyzed overnight against Tris-NaCl buffer to remove residual Tween 80 and ether, was used to immunize a (W/Fu X BN)F1 rat. The initial inoculum was emulsified in an equal volume of complete Freund's adjuvant and given subcutaneously at several sites. Subsequent immunizations were given at three weekly intervals and consisted of antigen emulsified in an equal volume of incomplete Freund's adjuvant, also injected subcutaneously at several sites. Serum was obtained 1 week after the third and fourth immunizations.
To remove antibodies against normal tissue components, the antiserum was absorbed with lyophilized extracts of normal monkey liver (30 mg/ml of antiserum) and lyophilized fetal calf serum (30 mg/ml of antiserum). Antiserum was mixed with the lyophilized powders and incubated overnight at 40C; the resulting precipitate was removed by centrifugation at 1000 X g for 30 min.
Reference precipitating antisera prepared against the group-specific (gs) antigens of avian sarcoma virus (AvSV) (4), murine leukemia virus (MuLV) (5), murine mammary tumor virus (MuMTV) (6), hamster sarcoma virus (HaSV) (7) , and feline leukemia virus (FeLV) (8) have been described. Viral antigens for immunodiffusion tests were prepared from ether-treated pellets of density-gradient isolated avian myeloblastosis virus (AvLV), MuLV, MuMTV, HaSV, and FeLV.
Immunodiffusion tests
For immunodiffusion analysis, soluble cellular extracts were prepared from tissues homogenized in 10 volumes of 0.85% NaCl solution for 3 min at medium speed in a "Virtis 45" homogenizer. The soluble proteins were obtained after centrifugation for 1 In negative-staining (Fig. 2) , the membrane of most particles appears smooth, similar to the smooth surface seen with leukemia-sarcoma viruses; this is in contrast to the spikecovered surface of murine mammary tumor virus. Occasionally, particles with irregular projections on the viral sur- 0). The head and tail configuration of this particle is an artefact caused by drying; nevertheless, it is a structural feature that is characteristic of the oncornaviruses. Note the absence of any surface projections of this particle. X 240,000. b, Negatively stained M-PMV. This particle has poorly defined small projections oii its surface. Only a small number of particles (<5%) in the simian virus preparation show this surface structure. X240,000. c, Internal structure of the M-PMV. This figure shows a damaged virion into which phosphotungstic acid has penetrated. The nucleocapsid is a helical structure (arrows), and is similar to the nucleocapsid of known oncornaviruses. X 300,000.
face also are observed. These projections are similar to those on the surface of avian myeloblastosis virus.
In most virions the nucleoprotein strands (30 A in diameter) are observed randomly oriented in the nucleoid, but in some instances, the strands are actually coiled in a helix 80 A in diameter (Fig. 2c) . A nucleocapsid helix of the same dimensions has been described in AvLV, MuLV, MuMTV, and FeLV (ref. 2 , and to be published). Effect of actinomycin on viral replication Fig. 4 shows that the addition of 0.5 Ag/ml of actinomycin D to the culture medium inhibits viral production.
Assay for RNA-dependent DNA polymerase
The virus preparations described here were tested by Dr. Jeffrey Schlom (Columbia University) and found to contain the RNA-directed DNA polymerase that is characteristic of oncornaviruses (11) .
In summary, M-PMV has several features that are similar to those of known oncornaviruses; it has a 60-70S RNA, it has the enzymes necessary for reverse transcription, the morphological features of its replication are essentially the same as those of the known oncornaviruses, and its replication is inhibited by actinomycin. Yet the biological activity of the virus is still unknown, and, for this reason, this virus cannot be classified with certainty as a mammary tumor agent. The possibility remains that this agent may be a leukemia virus.
Immunodiffusion tests with M-PMV and known oncornaviruses
Antisera prepared against M-PMV disrupted with Tween 80 and ether initially reacted in immunodiffusion tests with extracts of normal Rhesus-monkey tissues (separate extracts of liver, spleen, and kidney). Absorption of this antiserum with liver powder and fetal calf serum abolished all reactivity against normal monkey tissues and cells from an uninfected monkey embryo line (CV-1). This absorbed serum detected two viral antigens in ether-treated M-PMV and in extracts of monkey embryo cells infected with M-PMVt, but does not react with known oncornaviruses-MuLV, MuMTV, HaSV, and FeLV (Fig. 5) or AvLV antigens (not shown). In recipt A rabbit antiserum (kindly provided by I)r. S. Ahmed; Charles Pfizer and Co., Inc.) prepared against ether-treated M-PMIV detects the same viral specificities as the antiserum described here. In immunodiffusion tests these antisera formed lines of identity with ether-treated M-PMV. M\uLV (oncornavirus control) were incubated overnight with 20 ,ug/ml ['H]uridine. 20 ml of fluid from each culture was first centrifuged at 1000 X g for 20 min and then layered directly upon a 20-ml sucrose density gradient (15-60%). The gradient (in the SW 27 rotor) was centrifuged for 3 hr at 23,000 rpm, the tube was punctured from the bottom, and 1-ml fractions were collected. The purified virus was pelleted and the RNA was extracted in 1 ml of Tris-NaCl buffer containing 0.5% sodium dodecyl sulfate, 1% mercaptoethanol, 0.01 M EDTA, and 0.05% yeast RNA carrier; this was then layered on a 5-20% sucrose gradient and centrifuged for 4 hr at 25,000 rpm (SW 27 rotor). The gradients were punctured from the bottom and 1-ml fractions were collected. After the addition of carrier (100 jug of bovine serum albumin per sample), the RNA was precipitated with trichloroacetic acid and collected on Millipore filters. Recently it has been reported that simian foamy virus (14) and visna virus (15, 16) contain the RNA-dependent DNA Actinomycin D (0.5 jig/ml) was added to one culture at the same time as label; the other culture served as an untreated control. Density-gradient centrifugation is described in Fig. 3 . Actinomycin-treated 0-0; untreated control 0-0. polymerase that is characteristic of the oncornaviruses. In fact, it has been suggested that the simian virus described here might actually be a foamy agent (15) .
Rat anti-M-PMV serum was tested in immunodiffusion and found negative with ether-treated preparations of simian foamy viruses (types 1, 2, and 3; kindly provided by Dr. S. (Fig. 6 ), but not with a noninfected monkey embryo line. Similarly, this antiserum reacted with human W138 cells infected with M-PMV but not with noninfected W138. All reactions were cytoplasmic (perinuclear); no nuclear fluorescence was observed.
Immunodiffusion and immunofluorescence tests for M-PMV antigens in human tumors Several human neoplastic lines maintained in tissue culture were screened by immunofluoresence tests for M-PMV antigens: five different breast cancer lines, an osteogenic sarcoma, and an ovarian tumor were negative.
The sera from 30 breast cancer patients were tested in immunodiffusion with ether-treated M-PMV. All but one of these sera were negative. The single positive reaction was directed against a component (gamma-fetal protein) of fetalcalf serum, a constituent of the culture medium in which the infected cells were grown. The immunological reactivity of cancer patients against gamma-fetal protein has been described previously (17) .
Thus, immunodiffusion studies show that M-PMV is serologically distinct from the known oncornaviruses, the visna virus, and three types of the simian foamy agent. Preliminary immunological analysis has failed to reveal the presence of M-PMV structural antigens in human neoplasia. However, the possibility still exists that this virus could be present in human cells in a cryptic form-i.e., similar to murine sarcoma virus in transformed nonproducer cells (18) .
